Introducing HETA Clinical: a new family of pan-cancer AI products that speed up pathology workflows and reduce failed molecular tests, starting with four that measure slide quality, tumor presence, mitoses and tumor cellularity. For research use only. aignostics.com/clinical/heta…
Introducing PathoSearch: a visual search engine for #pathology cases. From a single screenshot of a region of interest on an H&E slide, it retrieves morphologically similar, diagnosed reference cases in seconds. Now in early access: aignostics.com/products/path…
#PathTwitter #PathX
AIGNOSTICS retweeted
Big thanks to the @aignostics team for opening up RudolfV 2 to researchers 🤗
RudolfV 2 is a state-of-the-art pathology foundation model that analyzes tissue slides to support cancer detection and diagnosis. It also comes in lightweight versions, in case you need to run it with fewer resources.
Very excited to see how it helps researchers!
👉 Model on Hugging Face: huggingface.co/collections/A…
🌐 Blog post for a deeper look at the evaluation: aignostics.com/blog/rudolfv-…
First time at #ESPCongress — and we're bringing our first clinical application! 🎉
Booth #548: live demo of our clinical reference lookup for tough #pathology cases, plus latest on our H&E tissue profiling app.
Book a meeting: aignostics.com/contact?utm_s…
AIGNOSTICS retweeted
🧵I am excited to share that our paper: AI-Based Anomaly Detection for Clinical-Grade Histopathological Diagnostics has now been published in @NEJM_AI .
ai.nejm.org/doi/full/10.1056…
The #aignostics team is heading to #ASCO2024!
Interested in hearing about how we’re transforming precision medicine with our industry-leading foundation model and advanced machine learning algorithms? Let’s connect on June 2-3: lnkd.in/e7eTNxEw
#ASCO24 #PrecisionMedicine
We are delighted to announce that Aignostics has been awarded a 3 year grant under the “ProFIT” initiative. It was approved by the Investitionsbank Berlin (IBB) and is co-financed by the European Union under the EU Regional Development Fund (ERDF).
aignostics.com/news/aignosti…
We are thrilled to announce that we raised a €14m Series A led by @wellingtonvc - you can read the full press release here: aignostics.com/aignostics-ra…
Thank you @Forbes_DACH for selecting us as one of the top 30 startups in AI this year. We are excited to be part of this landscape!
forbes.at/artikel/forbes-ki-…
We are happy to share this new paper featuring our very own Miriam Haegele, @FKlauschen and Klaus-Robert Müller as co-authors, as well as our #ExplainableAI approach.
nature.com/articles/s42256-0…
Another interesting read featuring our founder @FKlauschen and our friends over at @vara_ai
berliner-zeitung.de/zukunft-…
Der virtuelle Assistent tagesspiegel.de/wissen/kuens…
We are happy to support #EMPAIA, which was officially kicked off today. EMPAIA is a large Charité-led consortium aimed at creating a neutral, vendor-agnostics platform to deploy AI applications into pathology labs, initially in Germany but hopefully soon also internationally.
We are thrilled to announce that we just closed a €5m Seed Round. A special thanks to @ChariteBerlin, @TUBerlin, @berlinnovation, and @ascenion for all the help!
#DigitalPathology #DigitalHealth #ExplainableAI
aignostics.com/aignostics-cl…
AIGNOSTICS retweeted
Digitales Bildanalysesystem unterstützt Pathologen bei Beurteilung mikroskopischer Präparate: Berlin – Wissenschaftler vom Pathologischen Institut der Charité – Universitätsmedizin Berlin haben gemeinsam mit Forschern… dlvr.it/RVcfnW #KI #Bildanalyse #Pathologie
AIGNOSTICS retweeted
The last European action plan against cancer dates back 30 years. In the meantime:
❗The world has changed.
❗Europe has changed.
❗And the number of cases is on the rise.
This is why on #WorldCancerDay, we begin a common path that will lead to Europe's Beating Cancer Action.
AIGNOSTICS retweeted
And if you'd like to learn more about machine learning, join the colloquium of @IRILifeSciences on Sep 26th where Frederick Klauschen will talk about machine learning applications in biomedicine t1p.de/t45o
New research from our colleagues on head and neck tumor metastasis analysis with AI - check it out here (German only for now):
aerzteblatt.de/nachrichten/1…
Read the latest research of our colleagues on explainable #ai in #pathology illustrating our precision approach
Resolving challenges in deep learning-based analyses of histopathological images using explanation methods
deepai.org/publication/resol…
by Miriam Hägele et al.
#DeepLearning #ReceiverOperatingCharacteristicCurve
AIGNOSTICS retweeted
Frederick Klauschen, Germany | Digital pathology - a prerequisite for precision medicine #ESPBilbao2018 #digitalPathology #molecularData
